Twist Bioscience (TWST) Gross Profit (2017 - 2026)

Twist Bioscience has disclosed Gross Profit across 10 years of filings, most recently posting $57.1 million for Q1 2026.

• In Q1 2026, Gross Profit rose 24.1% year-over-year to $57.1 million; the TTM figure through Mar 2026 stood at $213.2 million (up 31.32% YoY), while the FY2025 annual figure was $191.0 million, up 43.23% from the prior year.
• Gross Profit climbed to $57.1 million in Q1 2026, from $54.0 million in the prior quarter.
• Over the last five years, Gross Profit for TWST reached as high as $57.1 million in Q1 2026 and fell as low as $18.4 million in Q1 2022.
• The 5-year median for Gross Profit is $30.9 million (2024), against an average of $35.0 million.
• Annual changes were most pronounced in 2022 — Gross Profit jumped 78.48% — and 2023, when it retreated 12.9%.
• A 5-year view of Gross Profit shows it stood at $24.8 million in 2022, then rose by 16.78% to $29.0 million in 2023, then soared by 47.92% to $42.8 million in 2024, then increased by 25.99% to $54.0 million in 2025, then advanced by 5.84% to $57.1 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $57.1 million, $54.0 million, and $50.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.